The contract awarded to Evoqua renews a five-year agreement with the FDA where Evoqua has supplied reverse osmosis, control systems and deionization to meet its pure water needs. The contract also calls for Evoqua to provide ongoing service of the equipment and systems.
The company plans to double its capacity to manufacture water treatment products and has broken ground on a new production facility in Tewksbury, Massachusetts to replace its existing manufacturing in nearby Lowell.
Last month Evoqua launched its next-generation electrochemical desalination that utilizes tunable technology that the company says can reduce energy costs by as much as 30 percent in initial trials with the potential for even more.
